logo
  • Global Challenge
  • Our Approach
  • Partnering
  • Pipeline
  • Join Us
  • News & Events
  • Investors
    • Company Information
    • Board and Management
    • Advisors
    • Investor Alert
  • Publications
  • Contact

World Antibiotic Awareness Week Video

November 18, 2019
|In Alderley Park, News, Publications
|By Carl Curran

 

 

  • Prev
  • All Stories
  • Next

Related News

Infex strengthens Board with appointment of Professor Colm Leonard as Non-Executive Director

Infex Therapeutics is pleased to announce the appointment of Professor Colm Leonard as a…

Press Releases,Breaking News

Antimicrobial discovery and drug development – RSC Podcast

How do we develop drugs like antibiotics? How long does it take for such a drug to go…

Breaking News,Publications

Infex’s novel AMR drug candidate MET-X receives FDA QIDP designation

This designation gives MET-X an accelerated U.S. regulatory pathway and an additional…

Press Releases,Breaking News,Pipeline

Infex enters clinic with lead anti-virulence candidate RESP-X for Pseudomonas aeruginosa

Infex Therapeutics, a leading anti-infectives specialist, is pleased to announce the…

Press Releases,Breaking News,Pipeline

Infex Awarded Biomedical Catalyst Grant For COV-X Project

Infex Therapeutics, a leading anti-infectives specialist, is delighted to announce a…

Press Releases,Breaking News

COVID-19 Pandemic Triggers Upsurge in MBL Infections

New research has discovered that the ongoing COVID-19 pandemic has triggered a…

Breaking News,Pipeline

CARB-X Receives Additional $370m from U.S. Government and Wellcome

Enables continued investment in innovative projects to tackle the growing global threat…

News,Press Releases

Infex Therapeutics to begin clinical development of anti-virulence therapy for Pseudomonas aeruginosa (Pa) in non-cystic fibrosis bronchiectasis patients

MHRA grants approval of Phase 1 clinical trial, expected to start in H2 2022

News,Press Releases,Pipeline

Infex welcomes NICE and NHS England’s new antibiotic reimbursement mechanism

Infex Therapeutics, one of the UK’s leading infectious disease biotech companies, has…

News,Press Releases

© Infex Therapeutics Ltd. All rights reserved.